Huaige Capital has closed its third RMB-denominated fund at over 300 million yuan ($43 million), as the three-year-old investment firm steps up efforts to make the most of China’s fast-growing healthcare sector.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
